OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.000
-0.040 (-1.96%)
Oct 10, 2025, 3:05 PM EDT - Market open
OS Therapies Employees
As of December 31, 2024, OS Therapies had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change
1
Growth
25.00%
Revenue / Employee
n/a
Profits / Employee
-$3,250,384
Market Cap
63.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | 1 | 25.00% |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OSTX News
- 9 hours ago - OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma - Newsfile Corp
- 1 day ago - OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting - Newsfile Corp
- 3 days ago - OS Therapies to Participate in Fall 2025 Conferences and Events - Newsfile Corp
- 10 days ago - OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update - Newsfile Corp
- 21 days ago - OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDT - Newsfile Corp
- 4 weeks ago - OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b Prostate Cancer Clinical Trial Completes Last Visit - Newsfile Corp
- 4 weeks ago - Stonegate Capital Partners Initiates Coverage on OS Therapies Inc. (OSTX) - Newsfile Corp
- 5 weeks ago - OS Therapies to Participate in Upcoming Investor Conferences in September 2025 - Newsfile Corp